Literature DB >> 24246126

[Severe enteropathy with villous atrophy olmesartan medoxomil-associated].

Débora Nunge1, Matthieu Eoche2, Mathurin Fumery2, Eric Nguyen-Khac2, Valérie Gras1, Michel Andréjak3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24246126     DOI： 10.2515/therapie/2013057

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  4 in total

1.  Immunopathogenesis of olmesartan-associated enteropathy.

Authors:  E V Marietta; A M Nadeau; A K Cartee; I Singh; A Rishi; R S Choung; T-T Wu; A Rubio-Tapia; J A Murray
Journal:  Aliment Pharmacol Ther       Date:  2015-10-01       Impact factor: 8.171

2.  Olmesartan associated sprue-like enteropathy and colon perforation.

Authors:  Mahmoud Abdelghany; Luis Gonzalez; John Slater; Christopher Begley
Journal:  Case Rep Gastrointest Med       Date:  2014-03-04

Review 3.  Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.

Authors:  Ayesha Kamal; Christopher Fain; Angela Park; Peiqi Wang; Eduardo Gonzalez-Velez; Daniel A Leffler; Susan M Hutfless
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-01

4.  Rare Case of Olmesartan Induced Enteropathy.

Authors:  Richa Handa; Akhil Rahman; Vivek Kak
Journal:  Spartan Med Res J       Date:  2017-12-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.